Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PEPTERM
- Development stage
- Unknown
- Lead developer
- Biofield Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
PEPTERM is a multi-ingredient nutritional dietary supplement formulated as a tablet. It contains Carica papaya leaf extract (1000 mg), goat milk powder (100 mg), Tinospora cordifolia (150 mg), Swertia chirata (125 mg), and wheat germ oil (40 mg). Developed and marketed by Biofield Pharma, PEPTERM is primarily used as a platelet booster and immunity support supplement to help maintain healthy platelet counts, support digestion, and aid recovery from infections and illnesses such as dengue.
- Brand names
- PEPTERM
- Other names
- Carica papaya leaf + goat milk powder + Swertia chirata + Tinospora cordifolia + wheat germ oilPepterm Tablets
Beyond the preview
Go deeper on PEPTERM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PEPTERM.